Akt/PKB activates the IκB kinase (IKK), which is a positive regulator of the survival transcription factor NFκB, and it has been shown that Akt/PKB links NFκB to modulation of anti-apoptotic effects in lymphoma cells [78]. Here, AKT1 is linked to lymphoma.